Individualized prediction of survival benefits from perioperative chemoradiotherapy for patients with resectable gastric cancer.

The application of perioperative chemoradiotherapy should be determined according to the clinicopathological features of patients. Our nomogram provided a reliable tool for screening patients who were right for PCRT and evaluating individual survival benefits.